You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 240 No. 16, October 13, 1978 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Thrombophlebitis in Systemic Lupus Erythematosus

Brian Peck, MD; Gary S. Hoffman, MD; Walter A. Franck, MD

JAMA. 1978;240(16):1728-1730.


Abstract

Thrombophlebitis occurred in 14 (12.2%) of 114 patients with active systemic lupus erythematosus (SLE). Abnormal clotting occurred despite the presence of thrombocytopenia or circulating anticoagulants in some of the patients, and the development of pulmonary emboli was verified in seven. Although infrequently reported, the association of thrombophlebitis with active SLE is apparently not uncommon. While there were no features that distinguished this group of patients from other groups of patients with SLE, there are some possible mechanisms. Recognition of this complication of SLE is important because of the frequent occurrence of SLE-induced pleuritis and its similarity to the pain of pulmonary emboli.

(JAMA 240:1728-1730, 1978)



Author Affiliations

From the Department of Medicine, Connective Tissue Diseases Section, Dartmouth-Hitchcock Medical Center, Hanover, NH (Drs Peck, Hoffman), Department of Medicine, White River Junction Veterans Administration Hospital, White River Junction, Vt (Drs Peck and Hoffman), and the Mary Imogene Bassett Hospital, Cooperstown, NY (Drs Hoffman and Franck).


Footnotes

Reprint requests to Department of Medicine, Rheumatology Section, Mary Imogene Bassett Hospital, Cooperstown, NY 13326 (Dr Hoffman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Acquired Activated Protein C Resistance in Patients with Lupus Anticoagulant and Essential Thrombocythemia
Gabazza et al.
CLIN APPL THROMB HEMOST 1997;3:119-123.
ABSTRACT  

Review : Abnormalities in the protein C anticoagulant pathway detected by a novel assay using human thrombomodulin
Mohri et al.
Lupus 1997;6:590-596.
ABSTRACT  

Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders: Prevalence and Clinical Significance
Love and Santoro
ANN INTERN MED 1990;112:682-698.
ABSTRACT  

Embolic Stroke Complicating Systemic Lupus Erythematosus
Gorelick et al.
Arch Neurol 1985;42:813-815.
ABSTRACT  

Thrombosis in Systemic Lupus Erythematosus: Relation to the Presence of Circulating Anticoagulants
Glueck et al.
Arch Intern Med 1985;145:1389-1395.
ABSTRACT  

Thromboembolism in Patients With the 'Lupus'-Type Circulating Anticoagulant
Elias and Eldor
Arch Intern Med 1984;144:510-515.
ABSTRACT  

Renal Transplantation: Its Use in a Patient With Systemic Lupus Erythematosus and Complete Occlusion of Inferior Vena Cava
Waltzer et al.
Arch Surg 1980;115:987-988.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1978 American Medical Association. All Rights Reserved.